Bonnie L. Bassler - Dec 8, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Stock symbol
REGN
Transactions as of
Dec 8, 2022
Transactions value $
-$86,775
Form type
4
Date filed
12/12/2022, 03:35 PM
Previous filing
Sep 30, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $83K +218 +20.15% $380.95 1.3K Dec 8, 2022 Direct F1
transaction REGN Common Stock Sale -$170K -218 -16.77% $779.00 1.08K Dec 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -218 -4.4% $0.00 4.74K Dec 8, 2022 Common Stock 218 $380.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.